BioMarin develops and commercializes innovative
biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that address currently unmet medical needs; suggest a clear-cut development profile and provide an opportunity to be first-to-market.

One of the world's foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases.

Improving human and environmental health is the focus at
Perkin Elmers. From earlier insights and more effective therapies to cleaner water and safer buildings where we work, learn and play; PerkinElmer touches the lives of millions of people around the world every day.

Through science, innovation and applications expertise we're committed to transforming risk into safety, mystery into knowledge and ideas into action for a healthier today and a better tomorrow.

With the experience of over 30,000 clinical cases, Signature Genomic Laboratories remains the industry leader in microarray-based cytogenetic diagnostics providing clients the most comprehensive and accurate results available. Continuous innovation of products and services insures that samples are tested using state of the art technology. The development of Genoglyphix® software is one more example of how Signature Genomic Laboratories is leading the way. Learn more at www.signaturegenomics.com.